Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 3Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 12Breast 3Head & Neck 2Gynecologic 2Genitourinary 2Gastrointestinal 2Thoracic 1Plasma cell 1Other solid neoplasm 1NET 1Endocrine 1Dermatologic 1CNS 1

Conditions

Melanoma 390Skin Neoplasms 90Carcinoma, Non-Small-Cell Lung 79Breast Neoplasms 56Neoplasms 55Colorectal Neoplasms 53Lung Neoplasms 52Neoplasm Metastasis 46Ovarian Neoplasms 44Lymphoma, T-Cell, Cutaneous 44Carcinoma, Renal Cell 43Squamous Cell Carcinoma of Head and Neck 42Uveal Melanoma 39Pancreatic Neoplasms 38Sarcoma 36Carcinoma, Basal Cell 36Head and Neck Neoplasms 33Uterine Cervical Neoplasms 32Prostatic Neoplasms 32Stomach Neoplasms 31Carcinoma, Merkel Cell 30Carcinoma, Hepatocellular 30Endometrial Neoplasms 29Urinary Bladder Neoplasms 28Kidney Neoplasms 26Triple Negative Breast Neoplasms 24Esophageal Neoplasms 22Carcinoma, Squamous Cell 22Lymphoma 20Mycosis Fungoides 19

Interventions

pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Hemangiosarcoma × Dermatologic × Clear all
NCT05859074 2025-12-03

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting
56 enrolled
DermatologicHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Hemangiosarcoma, Melanoma, Neoplasm Metastasis, Neoplasms, Paget Disease, Extramammary, Sarcoma, Kaposi, Skin Neoplasms, Carcinoma, Merkel Cell, Adenocarcinoma, Sebaceous, Carcinoma, Skin Appendage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡